GlassScriptPhysician profile
Kyle Daro Buchanan
NPI 1447577655
$9,203.20
in general payments reported to CMS, 2019-2025
38 companies · $1,947 in 2025
The $1,947 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $352 · 2021: $950 · 2022: $1,012 · 2023: $1,914 · 2024: $2,434 · 2025: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,663 · Travel and Lodging: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,663.39 |
| Travel and Lodging | $1,630.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,360.17 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $1,305.62 | 2023-2024 | Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $962.35 | 2021-2025 | Avvigo Guidance System, Angiojet Ultra 5000a, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $949.87 | 2023-2025 | Impella |
| Abbott Laboratories | $727.03 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary |
| Pfizer INC. | $347.60 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $340.64 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $319.94 | 2019-2025 | Lifevest |
| Heartflow, INC. | $300.47 | 2019-2025 | |
| Cardiovascular Systems INC. | $245.23 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $208.34 | 2022-2025 | Corevalve Evolut R |
| Cvrx, INC. | $200.87 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $200.11 | 2021-2025 | Farxiga, Wainua |
| Zoll Circulation INC | $172.56 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Terumo Medical Corporation | $155.96 | 2024 | Glidesheath Slender |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.